National Framework Agreement for Adalimumab Injection 1 April 2023
What the buyer wrote
Project Title: NHS National Framework Agreement for the supply of Adalimumab Injection commencing 1 April 2023<br/> <br/>Offer reference number: CM/PHR/22/5660<br/> <br/>CM/PHR/22/5660/01 - NHS Framework Agreement for the supply of Adalimumab Injection to South of England. Period of framework: 1 April 2023 to 31 August 2024 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months<br/>CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab Injection to the Midlands and East. Period of framework: 1 April 2023 to 28 February 2025 with an option or options to extend (at the Authority’s discretion) for a period or peri…
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- National Framework Agreement for Adalimumab Injection 1 April 2023
- How they are buying
- Advertised, open to anyoneAny supplier could bid without being invited first.
- Type
- goods
- Lots
- 4
- Framework
- Yes: joining it lets you bid for call-offs without a new tender each time
- Kind of work
- Pharmacy and medicines
Who the buyer named
NHSE Commercial was the named contact on this notice.